Log In
Print
BCIQ
Print
Print this Print this
 

EPI-589

  Manage Alerts
Collapse Summary General Information
Company Edison Pharmaceuticals Inc.
DescriptionReversible redox cofactor
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationCentral nervous system (CNS) disorders
Indication DetailsTreat central nervous system (CNS) disorders in adults
Regulatory Designation

Partner

Sumitomo Dainippon Pharma Co. Ltd.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today